Function Oncology and Volastra Therapeutics Form Strategic Partnership to Enhance Precision Cancer Treatment

-Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovativ...

March 27, 2024 | Wednesday | News
FDA Approves Roche's First Molecular Test for Malaria Screening in Blood Donors

The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria Malaria is a serious and potentially fatal paras...

March 27, 2024 | Wednesday | News
Johnson & Johnson Announces FDA Approval of OPSYNVI® as First Once-Daily Single-Tablet Combo Therapy for Pulmonary Arterial Hypertension (PAH)

   Johnson & Johnson has announced the approval of OPSYNVI® by the U.S. Food and Drug Administration (FDA), marking a significant advanc...

March 25, 2024 | Monday | News
New Treatment Option for Prostate Cancer Shows Successful Outcomes

    Prostate cancer treatment traditionally involves radiation or surgery, both carrying risks of adverse effects like urinary incontinence and...

March 25, 2024 | Monday | News
Gilead Sciences Completes Acquisition of CymaBay, Strengthening Liver Disease Therapies

    “The acquisition of CymaBay brings us a potential best-in-disease therapy that could transform the treatment landscape for people wit...

March 25, 2024 | Monday | News
Positive CHMP Opinions for Bempedoic Acid and Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet

    “We are thrilled with the positive CHMP opinion, which reflects the significant cardiovascular risk reduction benefit that the bemped...

March 25, 2024 | Monday | News
Bayer and Thermo Fisher Scientific Join Forces to Expand Access to Precision Cancer Treatments

    The innovative partnership seeks to revolutionize decentralized genomic testing, offering swift turnaround times to identify individuals wh...

March 21, 2024 | Thursday | News
Australia's Telix Pharmaceuticals Forges Alliance to Drive Personalized Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX) has announced a strategic agreement to partner with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaf...

March 19, 2024 | Tuesday | News
AstraZeneca's Quantum Leap in Cancer Treatment: Acquires Fusion Pharmaceuticals for Next-Gen Radioconjugates

AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a trailblazing clinical-stage biopharmaceutical company speciali...

March 19, 2024 | Tuesday | News
Clarity Pharmaceuticals Advances Theranostic Prostate Cancer Trial to Multi-Dose Phase

    The completion of Cohort 3 marks a significant milestone, with six participants receiving therapy with 67Cu-SAR-bisPSMA at the highest sing...

March 18, 2024 | Monday | News
Labcorp's Latest Studies at SGO Meeting Herald New Era in Ovarian Cancer Biomarker Testing

In an effort to bridge testing gaps and facilitate targeted therapies for EOC patients, Labcorp conducted two seminal studies, illustrating the profound im...

March 18, 2024 | Monday | News
Fennec and Norgine Partner to Commercialize PEDMARQSI in Europe, Australia, and NZ

Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the Europea...

March 18, 2024 | Monday | News
Novo Holdings Joins €30M Series A Financing for Asgard Therapeutics, Leader in In Vivo Cell Reprogramming to Treat Cancer

Novo Holdings, a leading global life sciences investor, has announced its participation in a significant €30M Series A financing round for Asgard Ther...

March 14, 2024 | Thursday | News
Bayer and Aignostics Forge Innovative AI-driven Partnership to Advance Precision Oncology

Bayer and Aignostics GmbH, a pioneering force in computational pathology, have unveiled a landmark strategic partnership aimed at revolutionizing precision...

March 14, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close